I truly do not understand how you can have a management team this stupid to develop a molecule highly targeted to a specific site, yet, no pre-stratify the trial(s).
This is either just complete incompetence, or the drug isn't truly doing what they claim it is supposed to do.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.